0001192482-17-000214.txt : 20170804
0001192482-17-000214.hdr.sgml : 20170804
20170804161545
ACCESSION NUMBER: 0001192482-17-000214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170804
FILED AS OF DATE: 20170804
DATE AS OF CHANGE: 20170804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brannelly Paul
CENTRAL INDEX KEY: 0001394936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 171008811
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 2 MERCER ROAD
CITY: NATICK
STATE: MA
ZIP: 01760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-08-04
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001394936
Brannelly Paul
C/O COLLEGIUM PHARMACEUTICAL, INC.
780 DEDHAM STREET, SUITE 800
CANTON
MA
02021
0
1
0
0
Executive Vice President & CFO
Common Stock
2017-07-28
5
A
0
776
10.60
A
111003
D
Common Stock
2017-08-04
4
F
0
200
12.39
D
110803
D
Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
/s/ Paul Brannelly
2017-08-04